ENDOTHELIN-CONVERTING ENZYME-ACTIVITY IN HUMAN SERUM-LIPOPROTEIN FRACTION

被引:8
作者
OHWAKI, T [1 ]
SAKAI, H [1 ]
HIRATA, Y [1 ]
机构
[1] TOKYO MED & DENT UNIV,DEPT INTERNAL MED 2,BUNKYO KU,TOKYO 113,JAPAN
关键词
ENDOTHELIN; LIPOPROTEIN; ENDOTHELIN CONVERTING ENZYME;
D O I
10.1016/0014-5793(93)80084-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endothelin-1 (ET-1)-converting enzyme (ECE) activity in the human serum lipoprotein fraction was studied using a sensitive enzyme immunoassay and reverse-phase high performance liquid chromatography. The ECE activity of cleaving synthetic human big ET-1 into ET-1 by the serum lipoprotein fraction was about 14-times greater than that by whole serum, and the activity was closely associated with lipoprotein itself. The lipoprotein ECE activity, which was optimal at pH 7.0, was inhibited by EDTA, o-phenanthroline, phosphoramidon, thiorphan, phenylmethane-sulfonyl fluoride and chymostatin, but not by cysteine or aspartic proteinase inhibitors, suggesting metalloproteinase- and chymotrypsin-like properties. These results suggest that the serum lipoprotein ECE may be involved in the processing of big ET-1 to ET-1 in the circulatory system.
引用
收藏
页码:165 / 168
页数:4
相关论文
共 20 条
[1]  
BURSTEIN M, 1970, J LIPID RES, V11, P583
[2]   INHIBITION OF BIOLOGICAL ACTIONS OF BIG ENDOTHELIN-1 BY PHOSPHORAMIDON [J].
FUKURODA, T ;
NOGUCHI, K ;
TSUCHIDA, S ;
NISHIKIBE, M ;
IKEMOTO, F ;
OKADA, K ;
YANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (02) :390-395
[3]   ENDOTHELIN CONVERTING ENZYME OF BOVINE CAROTID-ARTERY SMOOTH MUSCLES [J].
HIOKI, Y ;
OKADA, K ;
ITO, H ;
MATSUYAMA, K ;
YANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 174 (02) :446-451
[4]   INCREASED PLASMA-IMMUNOREACTIVE ENDOTHELIN-1 CONCENTRATION IN HYPERCHOLESTEROLEMIC RATS [J].
HORIO, T ;
KOHNO, M ;
MURAKAWA, K ;
YASUNARI, K ;
YOKOKAWA, K ;
UEDA, M ;
TAKEDA, T .
ATHEROSCLEROSIS, 1991, 89 (2-3) :239-246
[5]   ENDOTHELIN-1 AND VASCULITIS [J].
KANNO, K ;
HIRATA, Y ;
NUMANO, F ;
EMORI, T ;
OHTA, K ;
SHICHIRI, M ;
MARUMO, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (22) :2868-2868
[6]   PUTATIVE PRECURSORS OF ENDOTHELIN HAVE LESS VASOCONSTRICTOR ACTIVITY INVITRO BUT A POTENT PRESSOR EFFECT INVIVO [J].
KASHIWABARA, T ;
INAGAKI, Y ;
OHTA, H ;
IWAMATSU, A ;
NOMIZU, M ;
MORITA, A ;
NISHIKORI, K .
FEBS LETTERS, 1989, 247 (01) :73-76
[7]   CONVERSION OF BIG ENDOTHELIN-1 TO 21-RESIDUE ENDOTHELIN-1 IS ESSENTIAL FOR EXPRESSION OF FULL VASOCONSTRICTOR ACTIVITY - STRUCTURE ACTIVITY RELATIONSHIPS OF BIG ENDOTHELIN-1 [J].
KIMURA, S ;
KASUYA, Y ;
SAWAMURA, T ;
SHINMI, O ;
SUGITA, Y ;
YANAGISAWA, M ;
GOTO, K ;
MASAKI, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S5-S7
[8]   CIRCULATING AND TISSUE ENDOTHELIN IMMUNOREACTIVITY IN ADVANCED ATHEROSCLEROSIS [J].
LERMAN, A ;
EDWARDS, BS ;
HALLETT, JW ;
HEUBLEIN, DM ;
SANDBERG, SM ;
BURNETT, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (14) :997-1001
[9]   CONVERSION OF BIG ENDOTHELIN-1 TO ENDOTHELIN-1 BY 2 TYPES OF METALLOPROTEINASES DERIVED FROM PORCINE AORTIC ENDOTHELIAL-CELLS [J].
MATSUMURA, Y ;
IKEGAWA, R ;
TSUKAHARA, Y ;
TAKAOKA, M ;
MORIMOTO, S .
FEBS LETTERS, 1990, 272 (1-2) :166-170
[10]   PHOSPHORAMIDON, A METALLOPROTEINASE INHIBITOR, SUPPRESSES THE HYPERTENSIVE EFFECT OF BIG ENDOTHELIN-1 [J].
MATSUMURA, Y ;
HISAKI, K ;
TAKAOKA, M ;
MORIMOTO, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 185 (01) :103-106